文献速递乳腺胸部CT

局部晚期乳腺癌内乳淋巴结检出率及其与转移性疾病的相关性:一项回顾性观察性研究

Incidence of internal mammary node in locally advanced breast cancer and its correlation with metastatic disease: a retrospective observational study.
PubMed 文献 · Br J Radiol · 2019-09-24

该回顾性观察性研究纳入182例局部晚期乳腺癌患者,由两位放射科医生独立审阅基线CT,检出内乳淋巴结者77例(42.3%),其中90.90%位于原发灶同侧、55.9%见于上外象限肿瘤、44.4%位于第二肋间隙。3年内36例(19.7%)发生远处转移,基线CT有内乳淋巴结者21例(27.3%)vs 无内乳淋巴结者15例(14.3%),差异有统计学意义(p=0.0321)。

要点

  • 局部晚期乳腺癌基线CT内乳淋巴结检出率为42.3%(77/182)。
  • 可辨认内乳淋巴结多数位于原发灶同侧(90.90%),上外象限肿瘤中发生率较高(55.9%)。
  • 基线CT有内乳淋巴结者3年内远处转移发生率27.3% vs 无内乳淋巴结者14.3%(p=0.0321)。

核心结论

  • 相当数量局部晚期乳腺癌患者在基线影像上可见内乳淋巴结,基线CT显示内乳淋巴结者治疗后转移性疾病发生率显著更高。

研究设计与样本

  • 回顾性观察性研究,纳入2012年1月1日至2014年12月31日局部晚期乳腺癌患者182例,基线CT由两位放射科医生独立审阅,分析3年随访结果。

关键影像表现/征象

  • 可辨认内乳淋巴结多数位于原发灶同侧(90.90%),在上外象限肿瘤患者中发生率较高(55.9%)。
  • 可辨认内乳淋巴结多数位于第二肋间隙(44.4%)。
  • 内乳淋巴结的判定基于大小、位置及其与乳腺原发灶位置的关系。

诊断标准与关键数值

  • 内乳淋巴结检出率42.3%(77/182)。
  • 3年内远处转移总发生率19.7%(36/182),其中有内乳淋巴结者27.3%(21例)、无内乳淋巴结者14.3%(15例),两组比较p=0.0321。

临床应用与阅片要点

  • 阅片时按大小、位置及与乳腺原发灶位置的关系记录内乳淋巴结。
  • 局部晚期乳腺癌基线CT发现内乳淋巴结者,随访中远处转移发生率更高(27.3% vs 14.3%,p=0.0321)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine incidence of internal mammary nodes (IMN) at baseline CT of locally advanced breast cancer (LABC) and ascertain prognostic implication.

METHODS AND MATERIALS: Retrospective review of all LABC patients from 1 January 2012 through 31 December 2014 was performed after approval from institutional review board. CTs of 182 patients enrolled were reviewed by two radiologists independently, and IMNs were documented based on size, location and relation with location of breast primary. 3-year follow-up was analysed and incidence of metastases was calculated as overall incidence, incidence in patients with and without discernible IMN at baseline imaging. Results are presented as numbers and percentages. Differences in metastases of two groups were compared using χ2 test. 95% CI was calculated and p < 0.05 was considered significant.

RESULTS: 77 of 182 had identifiable IMN (42.3% incidence). Majority of identifiable nodes were on ipsilateral side of primary (incidence 90.90%) with higher incidence in patients with upper-outer quadrant tumours (55.9%). Majority were seen in second intercostal space (44.4%). 36 (19.7%) developed distant metastases within 3 years of therapy. Of these, 21 (27.3%) had IMN as compared with 15 (14.3 %) without IMN on baseline imaging. Patients with identifiable IMN on baseline CT had significantly higher incidence of distant metastases (p = 0.0321).

CONCLUSION: Significant number LABC patients have identifiable IMN on baseline imaging with patients showing IMN on baseline CT showing significantly higher rate of metastatic disease following therapy.

ADVANCES IN KNOWLEDGE: Many LABC patients have identifiable IMNs on baseline imaging which show higher incidence of subsequent metastatic disease.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Singh S, Ramani SK, Rastogi A, et al. Incidence of internal mammary node in locally advanced breast cancer and its correlation with metastatic disease: a retrospective observational study. Br J Radiol. 2019. PMID: 31538515. doi:10.1259/bjr.20190098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。